On April 26–27, the 6th International Forum for Life Sciences and Veterinary Specialists will convene to address the development of the temperature-controlled pharmaceuticals and medical devices sector in Russia:

“PHARMA AND BIOTECH: REGULATORY FRAMEWORKS AND PHARMACEUTICAL BUSINESS DEVELOPMENT AMID ECONOMIC UNCERTAINTY.”

The forum will feature a roundtable session titled “Healthcare Financing, Procurement System Reform, and State Programs,” which will address the following key issues:

• Key trends in the regulation of public procurement for medicines and medical devices

• Reforming the state procurement system: primary innovations, regulatory risks, and commercial opportunities.
• Challenges regarding the legal description of procurement items.
• Current judicial trends and enforcement practice of the Federal Antimonopoly Service (FAS) of Russia.
• Assessing the legal implications of appointing the Ministry of Finance as the primary system operator. 
• Excluding cold chain requirements from procurement regulations: potential threats to pharmaceutical safety; navigating public procurement and regulatory red tape: strategic adaptation for suppliers.
• Developing the clinical trials sector in the Russian Federation: identifying missed opportunities 
• The healthcare budget and the development of the VED (Vital and Essential Drugs) system during economic volatility: future outlook
• Utilizing big data analytics to monitor public procurement and pharmaceutical pricing
• Strategic prospects for the drug serialization and tracking program in relation to the cold chain.